Home/Filings/4/0001415889-25-016386
4//SEC Filing

Piscitelli Dominic 4

Accession 0001415889-25-016386

CIK 0001796280other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 8:18 PM ET

Size

6.8 KB

Accession

0001415889-25-016386

Insider Transaction Report

Form 4
Period: 2025-06-06
Piscitelli Dominic
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-06-06$10.01/sh2,600$26,021104,164 total
  • Sale

    Common Stock

    2025-06-09$10.00/sh300$3,000103,864 total
Footnotes (2)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024.
  • [F2]Represents the weighted average share price of an aggregate total of 2,600 shares sold in the price range of $10.00 to $10.04 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

Oric Pharmaceuticals, Inc.

CIK 0001796280

Entity typeother

Related Parties

1
  • filerCIK 0001695028

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 8:18 PM ET
Size
6.8 KB